Stockholders' Equity Public Offerings (Details) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 9 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Oct. 28, 2021 |
Jul. 14, 2021 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Sep. 30, 2021 |
Jun. 30, 2021 |
Mar. 31, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
Class of Stock [Line Items] | ||||||||||
Number of shares of stock issued during period (in shares) | 7,500,000 | 10,000,000 | ||||||||
Price per share of common stock issued during period (in usd per share) | $ 25.872 | $ 25.68 | ||||||||
Issuance of stock, net of offering costs | $ 193,700 | $ 256,500 | $ 5,357 | $ 82 | $ 323 | $ 256,611 | $ 93 | $ 99 | ||
Days within which shares may be purchased by underwriters | 30 days | 30 days | ||||||||
Common Stock [Member] | ||||||||||
Class of Stock [Line Items] | ||||||||||
Number of shares of stock issued during period (in shares) | 272,847 | 10,012,898 | ||||||||
Common Stock [Member] | Over-Allotment Option [Member] | ||||||||||
Class of Stock [Line Items] | ||||||||||
Number of shares of stock issued during period (in shares) | 1,125,000 | 1,500,000 |
X | ||||||||||
- Definition Period which shares may be purchased by underwriters under a stock offering, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|